PapersFlow Research Brief
Cholesterol and Lipid Metabolism
Research Guide
What is Cholesterol and Lipid Metabolism?
Cholesterol and lipid metabolism refers to the biological processes regulating cholesterol homeostasis, including synthesis, uptake, efflux, and transport via regulators like SREBPs and LXRs, with key roles in preventing diseases such as atherosclerosis.
This field encompasses 41,377 papers on mechanisms involving LXR, SREBP, and ABCA1 in cholesterol efflux and homeostasis. SREBPs activate over 30 genes for cholesterol and fatty acid synthesis in the liver (Horton et al., 2002). Studies link cholesterol crystals to NLRP3 inflammasome activation in atherogenesis (Duewell et al., 2010).
Topic Hierarchy
Research Sub-Topics
SREBP Regulation of Cholesterol Synthesis
Researchers study sterol regulatory element-binding proteins (SREBPs) activation, nuclear translocation, and target gene regulation in hepatic cholesterol biosynthesis pathways. This includes proteolytic processing mechanisms and crosstalk with insulin signaling.
LXR-Mediated Cholesterol Efflux
This sub-topic examines liver X receptors (LXRs) as sensors of intracellular cholesterol that induce ABCA1/G1 expression for HDL-mediated efflux from macrophages and hepatocytes. Studies explore synthetic LXR agonists and their hypertriglyceridemic side effects.
ABCA1 in Reverse Cholesterol Transport
Research focuses on ATP-binding cassette transporter A1 (ABCA1) function in cellular cholesterol efflux to lipid-poor apoA-I, Tangier disease mutations, and macrophage foam cell formation. Investigations include lipidation mechanisms and regulatory phosphorylation.
Cholesterol Crystals in NLRP3 Inflammasome Activation
Scientists investigate cholesterol crystal-induced NLRP3 inflammasome assembly in macrophages, IL-1β secretion, and plaque destabilization in atherosclerosis. This encompasses crystal phagocytosis, lysosomal damage, and cathepsin B release pathways.
Phytosterols and Cholesterol Metabolism
Studies explore plant sterols' inhibition of intestinal cholesterol absorption via NPC1L1 competition, effects on LDL receptor activity, and clinical outcomes in sterol-enriched functional foods. Research addresses bioavailability and cardiovascular risk reduction.
Why It Matters
Cholesterol and lipid metabolism directly influences atherosclerosis, a leading cause of cardiovascular disease, through pathways like cholesterol efflux mediated by ABCA1 and inflammasome activation by cholesterol crystals. Horton et al. (2002) detailed how SREBPs regulate more than 30 genes for lipid synthesis, providing targets for therapies addressing hyperlipidemia. Duewell et al. (2010) demonstrated that NLRP3 inflammasomes, activated by cholesterol crystals, are required for atherogenesis in mouse models. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia, as shown by Abifadel et al. (2003), informing drugs like PCSK9 inhibitors that reduce LDL cholesterol by up to 60% in clinical use. Brown and Goldstein (1986) identified the receptor-mediated pathway for cholesterol homeostasis, foundational for statin development, which lowers cardiovascular events by 25-35% in trials.
Reading Guide
Where to Start
"A Receptor-Mediated Pathway for Cholesterol Homeostasis" by Brown and Goldstein (1986), as it provides the foundational mechanism of LDL receptor-mediated cholesterol uptake and feedback regulation essential for understanding subsequent advances.
Key Papers Explained
Brown and Goldstein (1986) established the receptor-mediated pathway for cholesterol homeostasis, which Brown and Goldstein (1997) extended to the SREBP proteolytic regulation of metabolism. Horton et al. (2002) built on this by detailing SREBPs' activation of over 30 lipid synthesis genes in liver. Duewell et al. (2010) connected these pathways to disease by showing cholesterol crystal-induced NLRP3 inflammasome activation in atherogenesis, while Abifadel et al. (2003) linked PCSK9 mutations to disrupted homeostasis.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current research emphasizes inflammasome roles in atherosclerosis (Duewell et al., 2010) and genetic loci for lipids (Teslovich et al., 2010), with no recent preprints available to indicate shifts.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | A Receptor-Mediated Pathway for Cholesterol Homeostasis | 1986 | Science | 5.7K | ✕ |
| 2 | Inflammation and Alzheimer's disease | 2000 | Neurobiology of Aging | 4.5K | ✓ |
| 3 | SREBPs: activators of the complete program of cholesterol and ... | 2002 | Journal of Clinical In... | 4.3K | ✓ |
| 4 | SREBPs: activators of the complete program of cholesterol and ... | 2002 | Journal of Clinical In... | 3.9K | ✓ |
| 5 | NLRP3 inflammasomes are required for atherogenesis and activat... | 2010 | Nature | 3.8K | ✓ |
| 6 | The SREBP Pathway: Regulation of Cholesterol Metabolism by Pro... | 1997 | Cell | 3.8K | ✓ |
| 7 | Biological, clinical and population relevance of 95 loci for b... | 2010 | Nature | 3.6K | ✓ |
| 8 | A SIMPLIFIED METHOD FOR THE ESTIMATION OF TOTAL CHOLESTEROL IN... | 1952 | Journal of Biological ... | 3.1K | ✓ |
| 9 | Atherosclerosis | 2001 | Cell | 3.0K | ✓ |
| 10 | Mutations in PCSK9 cause autosomal dominant hypercholesterolemia | 2003 | Nature Genetics | 3.0K | ✕ |
Frequently Asked Questions
What role do SREBPs play in cholesterol metabolism?
SREBPs are membrane-bound transcription factors that activate more than 30 genes for cholesterol and fatty acid synthesis and uptake in vertebrate cells. Horton et al. (2002) showed SREBPs regulate the complete program of lipid biosynthesis in the liver. This pathway maintains lipid homeostasis under sterol regulation.
How do cholesterol crystals contribute to atherosclerosis?
Cholesterol crystals activate NLRP3 inflammasomes, which are required for atherogenesis. Duewell et al. (2010) demonstrated this in mouse models lacking NLRP3 components, showing reduced plaque formation. The process links lipid metabolism to inflammation in macrophages.
What is the receptor-mediated pathway for cholesterol homeostasis?
The receptor-mediated pathway regulates cholesterol levels through LDL receptor endocytosis and feedback control. Brown and Goldstein (1986) described this mechanism in detail. It balances cellular cholesterol by adjusting receptor expression based on sterol levels.
How does PCSK9 affect cholesterol levels?
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia by increasing LDL cholesterol. Abifadel et al. (2003) identified these gain-of-function mutations in families with elevated LDL. PCSK9 degrades LDL receptors, reducing cholesterol clearance.
What genes influence blood lipid levels?
Genome-wide studies identified 95 loci associated with blood lipids like HDL, LDL, and triglycerides. Teslovich et al. (2010) validated these in over 100,000 individuals. The loci explain population variations in lipid traits relevant to cardiovascular risk.
How is the SREBP pathway regulated?
The SREBP pathway is controlled by proteolysis of a membrane-bound transcription factor in response to sterol levels. Brown and Goldstein (1997) outlined this regulation mechanism. Low cholesterol triggers SREBP cleavage and nuclear translocation for gene activation.
Open Research Questions
- ? How do interactions between SREBP and LXR pathways fine-tune cholesterol efflux in macrophages during atherosclerosis?
- ? What specific roles do ABCA1 polymorphisms play in HDL formation and reverse cholesterol transport?
- ? How do phytosterols modulate inflammation in cholesterol-loaded macrophages?
- ? Which downstream targets of NLRP3 activation by cholesterol crystals drive plaque instability?
- ? How do PCSK9 mutations interact with SREBP-regulated LDL receptor expression in hypercholesterolemia?
Recent Trends
The field includes 41,377 works with sustained interest in SREBP regulation (Horton et al., 2002, 4301 citations) and inflammasome activation by cholesterol crystals (Duewell et al., 2010, 3809 citations), but growth rate over 5 years is not available and no preprints or news from the last 12 months signal new directions.
Research Cholesterol and Lipid Metabolism with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Cholesterol and Lipid Metabolism with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers